Scanning for the Future (excerpt)

By Martin Berman-Gorvine
Israel Business Today, April 15, 1994
Israel's leading edge in high technology and medical research have come together in a new company called Myriad Ultrasound Systems Ltd. The company develops medical ultrasonic instruments for the diagnosis and monitoring of osteoporosis and other bone disorders. Its first product is the SoundScan™ 2000, which diagnoses and monitors osteoporosis. The instrument is currently undergoing clinical testing in the U.S., the U.K., Canada, Germany and Israel, and is patent pending.
[Company founder and Managing Director Alex] Rapoport notes that osteoporosis, the bone disorder which SoundScan 2000 is designed to detect, is a serious disorder which affects one in three women in the course of a lifetime. "Twenty percent of those who develop hip fractures die of complications within one year," Rapoport said. And the financial costs of the disease are almost as staggering as the human costs. Expenses total "$10 billion a year in the U.S. alone in direct and indirect costs," Rapoport said. The figure is expected to tise to $30 billion over the next 30 years, as the "baby boom" generation ages.
The SoundScan 2000 is only the first instrument Myriad Ultrasound has developed. The company said it is investing substantial resources in developing new products and applications. The firm's aim is to maintain the competitive advantage it belives it has in its bone fragility measurement system by introducing system upgrades and improvements. The possibilities are many for a new high-tech medical firm at the beginning of its road.
Original article copyright © 1994, Sagit Publishing International Ltd.
Back to top
Back to resume

Copyright © 2009, Martin Berman-Gorvine